Polygoni Cuspidati Rhizoma et Radix extract attenuates high-fat diet-induced NAFLD in rats: Impact on untargeted serum metabolomics and liver lipidomics
Pharmacological Research - Modern Chinese Medicine · 2023-12 · 9 · 100335
DOI: 10.1016/j.prmcm.2023.100335 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacological Research - Modern Chinese Medicine, 2023-12. Verfasst von Huan Zhang und 9 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Hong Kong Polytechnic University, General Research Fund of Shanghai Normal University, University Research Facility in Chemical and Environmental Analysis, Hong Kong Polytechnic University.
Abstract (Originalsprache)
Background
Polygoni Cuspidati Rhizoma et Radix (PCRR; the root and rhizome of Polygonum cuspidatum Sieb. et Zucc) has long been used to treat atherosclerosis, gastrointestinal disorders, and liver disease. However, the underlying mechanism of PCRR against liver steatosis remains unclear.
Purpose
The aim of this study was to determine the potential therapeutic targets and molecular mechanisms of PCRR in improving liver steatosis.
Methods
A high-fat diet (HFD)-induced simple steatosis model in rats was used to evaluate the therapeutic effect of polyphenol-rich water extract from PCRR. Its underlying mechanisms were revealed using untargeted mass spectrometry-based serum metabolomics, hepatic lipidomic profiling approaches, qPCR, and Western blotting assays.
Results
Our study showed that PCRR-treated rats displayed significant reduction of serum TC and LDL-C, hepatic TG, TC levels, and total liver lipid content under a HFD feeding condition. Untargeted metabolomics showed that PCRR significantly restored the overall levels of nine lipid classes in liver tissues and elevated the bile acid levels in the serum samples. We demonstrated that PCRR prevented HFD-induced hepatic steatosis by regulating the expressions of TG metabolism proteins, including p-AMPK, p-ACC, PPARα, and FAS, as well as the expressions of TC metabolism proteins, including p-AMPK, LDLR, and CYP7A1. Moreover, resveratrol and/or polydatin-derived metabolites were solely detected in the serum samples of the PCRR-treated group, indicating these microbial transformed metabolites might partly contribute to the beneficial effects of PCRR.
Conclusion
PCRR can be employed as a therapeutic agent to improve non-alcoholic fatty liver disease via regulating lipid metabolism.
Förderung
- Hong Kong Polytechnic University
- General Research Fund of Shanghai Normal University
- University Research Facility in Chemical and Environmental Analysis, Hong Kong Polytechnic University
- Hong Kong Government
Zitieren
APA
Zhang, H., Sham, T., Li, C., Wang, Y., Li, C., Cheng, K. K., So, C., Huang, Y., Chan, S., & Mok, D. K. (2023). Polygoni Cuspidati Rhizoma et Radix extract attenuates high-fat diet-induced NAFLD in rats: Impact on untargeted serum metabolomics and liver lipidomics. Pharmacological Research - Modern Chinese Medicine, 9, 100335. https://doi.org/10.1016/j.prmcm.2023.100335
Vancouver
Zhang H, Sham T, Li C, Wang Y, Li C, Cheng KK, et al. Polygoni Cuspidati Rhizoma et Radix extract attenuates high-fat diet-induced NAFLD in rats: Impact on untargeted serum metabolomics and liver lipidomics. Pharmacological Research - Modern Chinese Medicine. 2023;9:100335. doi:10.1016/j.prmcm.2023.100335
BibTeX
@article{Zhang2023,
author = {Zhang, Huan and Sham, Tung-Ting and Li, Chang and Wang, Yi and Li, Chen-yu and Cheng, Kenneth King-yip and So, Chun-Pang and Huang, Yu-yin and Chan, Shun-Wan and Mok, Daniel Kam-Wah},
title = {Polygoni Cuspidati Rhizoma et Radix extract attenuates high-fat diet-induced NAFLD in rats: Impact on untargeted serum metabolomics and liver lipidomics},
journal = {Pharmacological Research - Modern Chinese Medicine},
year = {2023},
volume = {9},
pages = {100335},
doi = {10.1016/j.prmcm.2023.100335}
}
EUVIMED